Skip to main content

  • The impact of elevated C-reactive protein levels on long-term outcomes of patients undergoing transcatheter aortic valve replacement

    • Posted: 01/31/2025
    • Author:

      Stephanie Brunner, Federico Moccetti, Lucca Loretz, Nina Conrad, Matthias Bossard, Adrian Attinger-Toller, Reto Kurmann, Florim Cuculi, Mathias Wolfrum and Stefan Toggweiler

    • NewsCRM

    Abstract

    Background

    In patients undergoing transcatheter aortic valve replacement (TAVR), elevated pre-procedural C-reactive protein (CRP) levels are frequently observed. Its impact on long-term results of TAVR is unclear. The aim of the study was to investigate the long-term (up to six years) clinical outcomes of TAVR patients with normal compared to elevated CRP levels before TAVR.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details